Nureca Q2 FY27: PAT ₹3.1 & Rev ₹40.3

Metric	Value
Revenue	₹40.3
Net Profit (PAT)	₹3.1

📢 Key Event
Nureca reports Q1 FY27 revenue of ₹40.3 crores, up 14% QoQ and 18% YoY.

🔄 What Changed
Operating profit margin improved to 8.7% from 7.3% QoQ; PAT rose to ₹3.1 crores from ₹0.9 crores YoY.

🔮 What's Next
The company projects market growth to ₹5,203 crores by 2030 at 9.9% CAGR and plans to expand manufacturing capacity in Punjab for medical devices and consumables.

💡 Investor Takeaway
Nureca is achieving profitable growth through its integrated healthcare platform and manufacturing expansion, with strong margins and rising profitability.

Nureca reported Q1 FY27 revenue of ₹40.3 crores, up 14% QoQ and 18% YoY, driven by strong gross margins and operating profitability. The company posted a PAT of ₹3.1 crores, reflecting significant improvement from prior periods. This performance marks the strongest quarterly results in 16 quarters, underscoring progress in its consumer healthcare platform strategy.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NURECA ✨ Ask AI About This

About Nureca Limited (NURECA)

Consumer Services · E-Commerce/App based Aggregator · Listed on NSE

Market Cap: ₹319.37 Cr P/E: 77.8 ROE: 2.4% ROCE: 5.2%

View full NURECA stock details →

📡 Get AI alerts when NURECA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NURECA — Free

💡 Ask AI about this filing

"How does Nureca's 9.9% CAGR market projection compare to peers?" "What is the timeline for the new Punjab manufacturing facility?" "What is the current valuation multiple relative to growth?"

Ask AI Free →

📊 More NURECA filings

See all NURECA filings →

🔥 Also filed on 21 July 2026

CYIENTDLM Cyient DLM Limited Financial Results KIOCL KIOCL Limited Insider Trading AARTIIND Aarti Industries Limited Financial Results ABCAPITAL Aditya Birla Capital Limited Announcement ANTHEM Anthem Biosciences Limited Financial Results RADICO Radico Khaitan Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NURECA files new disclosures

Track NURECA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NURECA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd